Q1 EPS Forecast for RAPT Therapeutics Increased by Analyst
RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) – Equities researchers at HC Wainwright lifted their Q1 2025 EPS estimates for RAPT Therapeutics in a note issued to investors on Monday, March 10th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings per share of ($0.16) for the quarter, up from their […]
RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) – Equities researchers at HC Wainwright lifted their Q1 2025 EPS estimates for RAPT Therapeutics in a note issued to investors on Monday, March 10th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings per share of ($0.16) for the quarter, up from their […]
